查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403390

到 2030 年分子生物酶市場預測：按產品、應用、最終用戶和地區分類的全球分析

Molecular Biology Enzymes Market Forecasts to 2030 - Global Analysis By Product (Enzymes, Kits & Reagents, DNA Extraction, Isothermal Amplification and Other Products), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2023年全球分子生物酶市場規模將達206億美元，預計2030年將達到590億美元，預測期內複合年成長率為16.2%。

在分子生物學中，酵素是一種特殊的蛋白質，可作為催化劑加速並促進生物體的代謝過程。酵素的工作原理是降低某些化學反應發生所需的活化能，加速這些反應，而不消耗或改變過程中的資源。酶是高度專業化的，因為它們是為了催化特定過程或一組相關事件而創建的。

根據世界衛生組織（WHO）的調查，約有12,368人流感病毒檢測呈陽性，其中8,423人（68.1%）感染甲型流感，3,945人（31.9%）感染B型流感。

成長動力：增加基因計劃

免疫系統疾病、代謝性疾病、癌症、先天性遺傳性疾病等疾病的發生和發展很大程度上受基因突變的影響。由於世界各地開展的基因組計劃數量不斷增加以及與遺傳分析相關的成本不斷下降，包括疾病治療、個體化醫療和微生物遺傳學在內的許多領域的研究正在取得進展。預計市場將受到這些需要使用各種酵素和試劑的程序的推動。

成長抑制因素：基因檢測報銷限制

保險報銷限制限制了基因檢測所需的某些分子生物酶的可用性。好的酶可能很昂貴。如果研究費用無法涵蓋全部費用，實驗室和研究中心可能會選擇使用更便宜的替代品，從而降低測試的準確性和效率。有限的報銷阻礙了創造更新、更有效率酵素的研發工作，從而阻礙了市場成長。

成長機會：不斷進步

分子生物學研究的不斷進步以及蛋白質組學、基因組學和重組 DNA 技術等行業對酶的各種應用的需求推動了對專用酶的需求。此外，重組 DNA、蛋白質工程和酶工程的進步正在生產具有增強特性的新酶，有助於擴大市場。

威脅：監管障礙

分子生物學中使用的酶，尤其是臨床和醫療環境中使用的酶，經常受到嚴格的監管監督。確保合規性和滿足監管要求可能是一個成本高且耗時的過程。遵守監管要求並完成新酶或修飾的核准流程可能既昂貴又耗時。這是限制市場拓展的主要因素。

COVID-19 的影響

研究目標的重點已在很大程度上從分子生物學的其他領域轉移到與 COVID-19 相關的研究。這正在影響用於各種研究和應用的特定酶品種的市場。由於人手不足、運輸限制和封鎖，供應鏈遭受了嚴重破壞。這影響了各種實驗室用品的可得性，包括分子生物學中使用的酵素。

預計在預測期內套件和試劑部分將是最大的

套件和試劑部分預計將成為預測期內最大的部分。這是由於這些產品在市場上的大量可得性、新的開發以及主要企業不斷推出的產品。由於克隆技術作為標準實驗室程序的持續發展以及分子生物學領域的擴展，預計酶在預測期內將以最快的速度成長。這使得製造商和供應商能夠提供多種用於核酸操作的酵素。

製藥和生物技術公司領域預計在預測期內複合年成長率最高

製藥和生物技術公司領域預計在預測期內複合年成長率最高。這是由促進工作流程的分子生物學產品的普及所推動的。隨著製藥和生技公司研究候選藥物、個體化醫療、診斷等，這些產品的便利性和有效性強化了他們的提案，從而增加了收益。未來幾年，分子技術階段研發和臨床試驗的廣泛採用將推動市場的發展。

比最大的地區

由於臨床和轉化研究方面的研究支出增加以及各國生物技術和製藥公司數量的快速增加，預計北美在預測期內將佔據最大的市場佔有率。慢性病在所有年齡層的盛行率以及癌症在社區中的普遍存在導致人們對預防和治療方案的研究不斷增加。老字型大小企業的存在和採用新技術的便利性被認為是推動該地區收益成長的主要因素。

複合年成長率最高的地區

預計亞太地區在預測期內將維持最高的複合年成長率。由於醫療保健系統不足、人口眾多、對針對性治療的需求不斷成長以及經濟快速擴張，分子生物學製造商看到了巨大的發展潛力。此外，正是這些國家不斷成長的消費能力，促使西方企業在這些國家推出新產品並獲得市場支配力，導致市場收益下降。

免費客製化服務：

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭關係

第5章全球分子生物酶市場：依產品

  • 酵素
    • 聚合酶
    • 限制性核酸內切酶
    • 逆轉錄酶
    • 連接酶
    • 磷酸酶
    • 蛋白酶和蛋白酶
  • 套件和試劑
    • 可冷凍乾燥和風乾
    • 下一代定序
    • 聚合酶鍊式反應
  • DNA萃取
  • 等溫擴增
  • 其他產品

第6章全球分子生物酶市場：依應用分類

  • 磊晶
  • 複製
  • 順序
  • 消化受限
  • 合成生物學
  • 其他用途

第7章全球分子生物學酶市場：依最終用戶分類

  • 學術研究所
  • 製藥和生物技術公司
  • 醫院和診斷中心
  • 其他最終用戶

第8章全球分子生物酶市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Illumina, Inc.
  • Merck KGAA
  • Bioline Technologies
  • Promega Corporation
  • Rockland Immunochemicals
  • Qiagen
  • Agilent Technologies, Inc.
  • Jena Bioscience GmbH
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Takara Bio, Inc.
  • LGC Limited
  • Bausch Health Companies Inc.
Product Code: SMRC24615

According to Stratistics MRC, the Global Molecular Biology Enzymes Market is accounted for $20.6 billion in 2023 and is expected to reach $59.0 billion by 2030 growing at a CAGR of 16.2% during the forecast period. In molecular biology, enzymes are specialized proteins that function as catalysts to quicken and ease metabolic processes in living things. They function by reducing the activation energy needed for a certain chemical reaction to take place, which speeds up these reactions without consuming any resources or changing them in the process. Because they are made to catalyze certain processes or groups of related events, enzymes are extremely specialized.

According to a survey conducted by the World Health Organization, approximately 12,368 individuals were positive for influenza viruses, of which 8,423 (68.1%) were typed as influenza A and 3,945 (31.9%) as influenza B.

Market Dynamics:

Driver:

Increasing amount of genomic projects

The genesis and progression of illnesses such immune system disorders, metabolic diseases, cancer, and inborn genetic disorders are significantly influenced by gene mutations. Research in a number of areas, including illness treatment, customized medicine, and microbial genetics, is advanced by the growing number of genome projects being undertaken worldwide and the declining costs associated with genetic analysis. The market is anticipated to be driven by these procedures, which call for the employment of a variety of enzymes and reagents.

Restraint:

Limited reimbursements for genetic testing

Reimbursement limitations limit the availability of specific molecular biology enzymes needed for genetic testing. Good enzymes can be costly; if reimbursements do not cover the entire cost, labs or research centers may choose to use less expensive substitutes, which may reduce test accuracy or efficiency. Research and development attempts to create newer, more efficient enzymes are hampered by limited reimbursement, which is hampering the growth of the market.

Opportunity:

Rising advancements

The need for specialized enzymes is driven by ongoing advances in molecular biology research as well as the necessity of enzymes for a variety of applications in industries including proteomics, genomics, and recombinant DNA technology. Additionally, advances in recombinant DNA, protein engineering, and enzyme engineering result in the production of new enzymes with enhanced characteristics, which propels market expansion.

Threat:

Regulatory hurdles

Strict regulatory oversight is frequently imposed on enzymes utilized in molecular biology, particularly when these enzymes are used in clinical or medical contexts. Ensuring compliance and meeting regulatory requirements may be costly and time-consuming procedures. It can be costly and time-consuming to comply with regulatory requirements and go through the approval procedures for new enzymes or changes. This is the main factor limiting the market's expansion.

COVID-19 Impact:

The focus of research goals moved significantly from other fields of molecular biology study to COVID-19-related investigations. This has an effect on the market for certain enzyme varieties utilized in various studies and applications. The supply chain experienced major interruptions as a result of manpower constraints, transit restrictions, and lockdowns. This has an impact on the availability of various lab supplies including enzymes used in molecular biology.

The kits & reagents segment is expected to be the largest during the forecast period

The kits & reagents segment is expected to be the largest during the forecast period. This can be attributed to the vast availability of these products in the market space, novel developments, and continuous product launches from key players. Enzymes are expected to rise at the quickest rate over the projection period due to the ongoing development of cloning technology as a standard laboratory procedure and the expanding field of molecular biology. This has allowed the manufacturers and suppliers to provide multiple enzymes for nucleic acid manipulation.

The pharmaceutical & biotechnology companies segment is expected to have the highest CAGR during the forecast period

The pharmaceutical & biotechnology companies segment is expected to have the highest CAGR during the forecast period. This can be attributed to the widespread adoption of molecular biology products that facilitate workflow. The convenience and effectiveness of these goods during the pharma and biotech businesses' research for drug candidates, customized medicine, or diagnostics enhances their offers and, as a result, increases revenues. In the upcoming years, the market will be driven by the widespread adoption of molecular technologies by businesses throughout the R&D and clinical trials phases.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to increase in research funds in clinical & translational research and surge in number of biotechnology & pharmaceutical companies in nations. Research on preventive and treatment options is growing due to the prevalence of chronic illnesses in all age groups and the ubiquity of cancer in the community. The presence of well-established players ease of adoption of new technologies are considered to be the major factors fueling revenue generation in this region.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period the presence of bio-clusters in the nations. Manufacturers of molecular biology have found great development potential due to the deficient healthcare systems, large population, increased need for focused therapeutics, and quick economic expansion. Further encouraging western corporations to introduce new goods and win market dominance in these countries is the rising spending power of these nations, which in turn has increased market revenue.

Key players in the market:

Some of the key players in Molecular Biology Enzymes market include Illumina, Inc., Merck KGAA, Bioline Technologies, Promega Corporation, Rockland Immunochemicals, Qiagen, Agilent Technologies, Inc., Jena Bioscience GmbH, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Takara Bio, Inc., LGC Limited and Bausch Health Companies Inc.

Key Developments:

In October 2022, Illumina Inc. announced strategic research collaboration with AstraZeneca, a global, science-led biopharmaceutical company, to accelerate drug target discovery by combining their strengths in artificial intelligence (AI) based genome interpretation and genomic analysis techniques along with industry expertise.

In September 2021, Thermo Fisher Scientific has announced the launch of its fully-automated analyzers specifically designed for enzyme assay applications. The systems combine hardware and new custom-designed software to deliver fully automated incubation settings, reagent additions and precise measurement calculations, all at the touch of a button.

Products Covered:

  • Enzymes
  • Kits & Reagents
  • DNA Extraction
  • Isothermal Amplification
  • Other Products

Applications Covered:

Polymerase Chain Reaction (PCR)

  • Epigenetics
  • Cloning
  • Sequencing
  • Restriction Digestion
  • Synthetic Biology
  • Other Applications

End Users Covered:

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Centres
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Molecular Biology Enzymes Market, By Product

  • 5.1 Introduction
  • 5.2 Enzymes
    • 5.2.1 Polymerases
    • 5.2.2 Restriction Endonucleases
    • 5.2.3 Reverse Transcriptases
    • 5.2.4 Ligases
    • 5.2.5 Phosphatases
    • 5.2.6 Proteases and Proteinases
  • 5.3 Kits & Reagents
    • 5.3.1 Lyophilisable and Air Dryable
    • 5.3.2 Next-Generation Sequencing
    • 5.3.3 Polymerase Chain Reaction
  • 5.4 DNA Extraction
  • 5.5 Isothermal Amplification
  • 5.6 Other Products

6 Global Molecular Biology Enzymes Market, By Application

  • 6.1 Introduction

6.2 Epigenetics

  • 6.3 Cloning
  • 6.4 Sequencing
  • 6.5 Restriction Digestion
  • 6.6 Synthetic Biology
  • 6.7 Other Applications

7 Global Molecular Biology Enzymes Market, By End User

  • 7.1 Introduction
  • 7.2 Academic & Research Institutes
  • 7.3 Pharmaceutical & Biotechnology Companies
  • 7.4 Hospitals & Diagnostic Centres
  • 7.5 Other End Users

8 Global Molecular Biology Enzymes Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Illumina, Inc.
  • 10.2 Merck KGAA
  • 10.3 Bioline Technologies
  • 10.4 Promega Corporation
  • 10.5 Rockland Immunochemicals
  • 10.6 Qiagen
  • 10.7 Agilent Technologies, Inc.
  • 10.8 Jena Bioscience GmbH
  • 10.9 Thermo Fisher Scientific, Inc.
  • 10.10 F. Hoffmann-La Roche Ltd.
  • 10.11 Bio-Rad Laboratories, Inc.
  • 10.12 Takara Bio, Inc.
  • 10.13 LGC Limited
  • 10.14 Bausch Health Companies Inc.

List of Tables

  • Table 1 Global Molecular Biology Enzymes Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Molecular Biology Enzymes Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Molecular Biology Enzymes Market Outlook, By Enzymes (2021-2030) ($MN)
  • Table 4 Global Molecular Biology Enzymes Market Outlook, By Polymerases (2021-2030) ($MN)
  • Table 5 Global Molecular Biology Enzymes Market Outlook, By Restriction Endonucleases (2021-2030) ($MN)
  • Table 6 Global Molecular Biology Enzymes Market Outlook, By Reverse Transcriptases (2021-2030) ($MN)
  • Table 7 Global Molecular Biology Enzymes Market Outlook, By Ligases (2021-2030) ($MN)
  • Table 8 Global Molecular Biology Enzymes Market Outlook, By Phosphatases (2021-2030) ($MN)
  • Table 9 Global Molecular Biology Enzymes Market Outlook, By Proteases and Proteinases (2021-2030) ($MN)
  • Table 10 Global Molecular Biology Enzymes Market Outlook, By Kits & Reagents (2021-2030) ($MN)
  • Table 11 Global Molecular Biology Enzymes Market Outlook, By Lyophilisable and Air Dryable (2021-2030) ($MN)
  • Table 12 Global Molecular Biology Enzymes Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
  • Table 13 Global Molecular Biology Enzymes Market Outlook, By DNA Extraction (2021-2030) ($MN)
  • Table 14 Global Molecular Biology Enzymes Market Outlook, By Isothermal Amplification (2021-2030) ($MN)
  • Table 15 Global Molecular Biology Enzymes Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 16 Global Molecular Biology Enzymes Market Outlook, By Application (2021-2030) ($MN)
  • Table 17 Global Molecular Biology Enzymes Market Outlook, By Polymerase Chain Reaction (2021-2030) ($MN)
  • Table 18 Global Molecular Biology Enzymes Market Outlook, By Epigenetics (2021-2030) ($MN)
  • Table 19 Global Molecular Biology Enzymes Market Outlook, By Cloning (2021-2030) ($MN)
  • Table 20 Global Molecular Biology Enzymes Market Outlook, By Sequencing (2021-2030) ($MN)
  • Table 21 Global Molecular Biology Enzymes Market Outlook, By Restriction Digestion (2021-2030) ($MN)
  • Table 22 Global Molecular Biology Enzymes Market Outlook, By Synthetic Biology (2021-2030) ($MN)
  • Table 23 Global Molecular Biology Enzymes Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 24 Global Molecular Biology Enzymes Market Outlook, By End User (2021-2030) ($MN)
  • Table 25 Global Molecular Biology Enzymes Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 26 Global Molecular Biology Enzymes Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 27 Global Molecular Biology Enzymes Market Outlook, By Hospitals & Diagnostic Centres (2021-2030) ($MN)
  • Table 28 Global Molecular Biology Enzymes Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.